Expertise in
2
conditions

Stephen M. Davis

Grattan Street, 
Parkville, VIC, AU 
Expertise in
2
conditions
Grattan Street, 
Parkville, VIC, AU 
OverviewLocationsClinical Research

Overview

Stephen Davis practices in Parkville, Australia. Mr. Davis is highly rated in 2 conditions, according to our data. His top areas of expertise are Stroke, Ventricular Fibrillation, Transient Ischemic Attack (TIA), Thrombectomy, and Embolectomy.

His clinical research consists of co-authoring 368 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Grattan Street, Parkville, VIC 3050, Australia
Other Locations
72 King William Road, North Adelaide, SA 5006, Australia
Grattan Street, Parkville, VIC 3052, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units. A Phase II Randomised, Placebo-controlled, Investigator-driven Trial of Tranexamic Acid Within 2 Hours of Intracerebral Haemorrhage
STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units. A Phase II Randomised, Placebo-controlled, Investigator-driven Trial of Tranexamic Acid Within 2 Hours of Intracerebral Haemorrhage
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Drug: Tranexamic Acid
Study Phase: Phase 2
A Multicentre, Randomised Controlled Trial of Exenatide Versus Standard Care in Acute Ischemic Stroke (TEXAIS)
A Multicentre, Randomised Controlled Trial of Exenatide Versus Standard Care in Acute Ischemic Stroke (TEXAIS)
Enrollment Status: Unknown
Publish Date: September 14, 2021
Intervention Type: Drug
Study Drug: Exenatide
Study Phase: Phase 2
STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial.
STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial.
Enrollment Status: Completed
Publish Date: February 26, 2020
Intervention Type: Drug
Study Phase: Phase 2
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Enrollment Status: Terminated
Publish Date: December 04, 2018
Intervention Type: Drug
Study Phase: Phase 3
Extending the Time for Thrombolysis in Emergency Neurological Deficits
Extending the Time for Thrombolysis in Emergency Neurological Deficits
Enrollment Status: Completed
Publish Date: August 31, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

368 Total Publications

Efficacy of Tenecteplase in Large Vessel Occlusion Stroke Within 24 Hours of Symptom Onset: The ETERNAL-LVO Randomized Controlled Trial.
Efficacy of Tenecteplase in Large Vessel Occlusion Stroke Within 24 Hours of Symptom Onset: The ETERNAL-LVO Randomized Controlled Trial.
Journal: Stroke
Published: September 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Davis's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile